Study reveals how SARS-CoV-2 variants of concern modulate receptor and antibody binding

News-Medical.Net Life Sciences | August 2021

In a trailblazing engineering effort, Canadian and US researchers indicate that the emergence of novel variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stems from the mutations of spike glycoprotein that confer either increased affinity for the host cell receptor or increased antibody evasion.